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Wedescribe themedicinal plantsthat havebeen reported to be antitumoragents andthat havebeen used in ethnobotanic research
in Brazil to answer the following questions: what is the abundance of plants reported to be antitumor in Brazil? Have the plant
species used for tumor treatment in traditional Brazilianmedicine been suﬃciently examined scientiﬁcally? Our analysis included
papers published between 1980 and 2008. A total of 84 medicinal plant species were reported to be used for cancer and tumor
prevention or treatment; 69.05% of these were cited as being used for the treatment of tumors and cancer in general and 30.95%
for speciﬁc tumors or cancers. The plants that were cited at a higher frequency were Aloe vera, Euphorbia tirucalli,a n dTabebuia
impetiginosa. At least, one pharmacological study was found for 35.71% of the species. Majority of the studies selected were
conducted in rural communities and urban areas and in areas withtraditional healers in Brazil.Wefound the followingmolecules
to be the most studied in vitro and in vivo: silibinin, β-lapachone, plumbagin and capsaicin.The species addressed here constitute
interesting objects for future studies to various professionals in the ﬁeld of natural products.
1.Introduction
In Brazil, it is estimated that there will be more than 489,270
new cases of cancer in 2011 [1]. Also known as neoplastic
tumors, malignant tumors are characterized by uncontrolled
growth of transformed cells [2], which can rupture the basal
membrane, attack and invade the surrounding tissues, and
may metastasize [3].
There are some limitations in the treatment of cancer
with chemotherapy, that in general provoke various toxic
reactions [4].Inaddition,solidtumorsare generallyresistant
to chemotherapy due to the inability of the drugs to access
hypoxic cells [5]. Moreover, many antineoplastic agents are
not speciﬁc to cancer cells and can also damage healthy cells,
especially those with rapid turnover, such as gastrointestinal
and immune cells [2]. Because of this, many patients with
cancer around the world have resorted to complementary
and alternative therapies as adjuvant treatment in relation to
oﬃcial (radiation, chemotherapy, and surgery), as the use of
plants [6].
Plant diversity is an important source of new molecules.
More than 60% of the anticancer agents used today are
derived directly or indirectly from natural sources [7].
Higher plants have been one of the largest sources of new
compounds with pharmacological activity. For example,
the species Catharanthus roseus (L.) G. Don (Apocynaceae)
produces several alkaloids, two of which, vincristine and
vinblastine, have anticancer activity [4]. Taxus brevifolia
Nutt., paciﬁc yew, produces a diterpenic alkaloid known
as taxol, which has been shown to act against advanced
ovarian cancer [8]. β-lapachone and lapachol are extracted
from the bark of Tabebuia impetiginosa (Mart. ex DC.)2 Evidence-Based Complementary and Alternative Medicine
Standl, which is native to Brazil; lapachol is sold in Brazil
by Pernambuco Pharmaceutical Laboratory (LAFEPE) and
is used for treatment of various neoplasias.
Ethnobotanical approach is a strategy that has suc-
cessfully identiﬁed new bioactive molecules from diverse
plants. In this approach, the information obtained from
traditional communities about the use of medicinal plants is
combinedwithchemical/pharmacologicalstudiesperformed
in laboratories [9]. This strategy has been helpful in plant
pharmacological research and has yielded better results than
the random approach used in diﬀerent experimental models
[10, 11].
Brazil is the country with the highest plant diversity
on the planet, with approximately 55,000 species of higher
plants [12] distributed in several ecosystems: Atlantic forest,
Amazon Forest, Cerrado, Caatinga, Pantanal, and Pampas.
In addition, the country also has an enormous cultural
diversity that is reﬂected in the diﬀerent ways its natural
resources are used [13]. In general, the use of medicinal
plants in Brazil is strongly inﬂuenced by the cultural
miscegenation, the introduction of exotic species by Africans
and Europeans since the times of the colonization and the
native indigenous people who make use of the local plant
diversity. Such immense plant and cultural diversity has
favoredthediversiﬁcationofapopularpharmacopoeiabased
on medicinal plants [14].
This study presents a review of the medicinal plants
reported in ethnobotanical studies conducted in Brazil that
have antitumor properties. Our results aimed to answer the
following two questions: (1) what is the abundance of plants
reported to be antitumor properties in Brazil? and (2) have
the plant species used for tumor treatment in traditional
Brazilian medicine been suﬃciently examined scientiﬁcally?
2.Materialsand Methods
2.1. Survey and Study Selection. Our survey of ethnobotan-
ical studies was performed using ﬁve databases (SCIELO,
SCIRUS, SCOPUS, BIOLOGICAL ABSTRACTS, and WEB
OF SCIENCE) using the following four combinations of
keywords: ethnobotany AND Brazil AND medicinal plants,
ethnobotanyANDBrazilianmedicinalplants,ethnopharma-
cology AND Brazil AND medicinal plants, and ethnophar-
macology AND Brazilian medicinal plants. Our analysis
includedpapers published between 1980 and 2008. From the
studies obtained from our search, we selected only those of
an ethnobotanical nature performed in Brazil and that cited
at least one plant with popular antitumor properties. All
information regarding the plant and its use, such as popular
name,species,plantpart,therapeuticindication,community
type, biome, and location, where the study was carried out,
was takendirectly from the selected reports. Forouranalysis,
we considered all of the plants as those that were popularly
recommended for the treatment of tumors and/or cancer in
general or for the treatment of more speciﬁc cancers, such as
leukemia,warts, or cancers of speciﬁc organs or human body
parts.
Some studies did not specify the culture of the pop-
ulation studied (e.g., indigenous, farmers, quilombola, or
urban), and in those cases, we designated it as a “local pop-
ulation.” The Brazilian ecosystems were classiﬁed as Ama-
zon, Cerrado (Brazilian savanna), Atlantic forest, Caatinga
(tropicaldrylands),Pantanal(tropicalwetland),andPampas
(South America plain), as deﬁned by the Brazilian Institute
of Geography and Statistics (IBGE). In those studies, where
the biome type was not provided, the correct biome was
obtained from the IBGE, to supplement the data.
The frequency or the number of times a given plant
species was cited in the diﬀerent studies analyzed was
recorded. Pharmacological studies on the classiﬁed plants
was veriﬁed in the aforementioned databases using the
following keyword combinations: species name AND tumor
and species name AND cancer. For the species names, all of
the scientiﬁc synonyms listed in the database of the Missouri
Botanical Garden (http://www.tropicos.org/)w e r eu s e d .F o r
the evaluation of the pharmacological studies available for
each plant species, we considered both in vitro and in vivo
studies related to cancer or tumors in humans and animals.
3.Results
3.1. Survey of Ethnobotanical Studies. Out of 293 studies
found using the diﬀerent keyword combinations, 39 were
selected according to the inclusion criteria. Of these selected
studies, 89.7% were published between 2000 and 2008. We
did not ﬁnd any studies published during the 1980s. Six
bibliographic review papers contained the highest number
of plant species cited as antitumor (X = 8.67). Reports
considered reviews were those that used data from the
published primary literature. The average number of plant
species cited, without taking reviews into account, was 2.15.
If we took into account all studies including reviews, the
average number of species cited was 3.74. The similarity
between the plant species cited in the reviews and the
primary literature was 29.76%.
Majority of the studies were performed in rural com-
munities (farm areas) and urban areas and in areas with
traditional healers (>82%). A minority of the studies were
performed with indigenous and Quilombola populations.
We found that a higher number of plants were cited as
being antitumor in the Caatinga (27.38%; 23 spp.), Cerrado
(25.0%; 21 spp.) and Atlantic forest (22.6%; 19 spp.),
ecosystems. Communities in the Amazon Forest and the
Pampas were each represented in 5.61% of the studies,
which corresponds to six species. The studies that did not
specify the type of vegetationor the location where the study
was carried out but that were inﬂuenced by two diﬀerent
types of ecosystems corresponded to 20.51% of the studies,
representing a total of 41 plant species cited. There was a
14.29% similarity between the species found in two or more
ecosystems.
3.2. Survey of Ethnobotanical Studies. A total of 84 medic-
inal plant species were reported in the ethnobotani-
cal/ethnopharmacological literature as being used for the
treatment or prevention of cancer and tumors, and these
species were distributed among 42 families and 63 generaEvidence-Based Complementary and Alternative Medicine 3
Table 1: Species of medicinal plants cited as being antitumor by traditional and nontraditionalcommunities in Brazilwith their plant parts
used, indication, occurrence, and pharmacological studies.
Family/species Plant parts used Indication Pharmacological
study/molecules evaluated
Occurrence
(reference)
Amaranthaceae
Iresine herbstii Hook Leaf Cancer — 2[ 15, 16]
Anacardiaceae
Anacardium occidentale L. Resin Wart
In vitro, in vivo and
clinical/Anacardic acid,
polysaccharides,
oligosaccharides, β-galactose,
and proteins [17–20]
2[ 21, 22]
Myracrodruon urundeuva Allem˜ ao Bark Tumors,
neoplasias — 2[ 23, 24]
Annonaceae
Rollinia leptopetala R.E. Fr. Bark Tumors — 2[ 22, 25]
Rolliniopsis leptopetala (R.E. Fr.) Saﬀ.B a r k T u m o r s — 1[ 13]
Apocynaceae
Forsteronia refracta M¨ ull. Arg. Latex Cancer In vitro/SL0101 (a kaempferol
glycoside) [26] 1[ 27]
Hancornia speciosa Gomes Latex Cancer In vitro [28] 1[ 29]
Himatanthus articulatus (Vahl) Woodson Latex Tumors,
cancer —1 [ 22]
Himatanthus bracteatus (A. DC.) Woodson Latex Tumors,
cancer — 1[ 22]
Himatanthus obovatus (M¨ ull. Arg.) Woodson Latex Cancer In vitro [30] 1[ 31]
Macrosiphonia velame (A. St.-Hil.) M¨ ull. Arg. Whole plant,
root Tumors — 1[ 31]
Arecaceae
Orbignya phalerata Mart. Fruit Leukemia In vitro [32] 1[ 22]
Asclepiadaceae
Marsdenia altissima (Jacq.) Dugand Bark Cancer — 1[ 22]
Asteraceae
Acanthospermum hispidum DC. Leaf, ﬂower,
root Cancer In vitro and in vivo [33, 34] 2[ 35, 36]
Aster squamatus (Spreng.) Hieron. Aerial parts Cancer — 2[ 15, 37]
Calendula oﬃcinalis L. Whole plant Cancer
In vitro and in vivo/calenduloside
F6 -O-n-butyl-ester and
calenduloside G 6-O-methyl
ester [38]
1[ 15]
Silybum marianum (L.) Gaertn. — Internal
tumors
In vitro and in vivo/silybinin and
silimarin [39, 40]
1[ 16]
Bignoniaceae
Tabebuia impetiginosa (Mart. ex DC.) Standl. Bark, ﬂower,
bast
Cancer and
tumors
In vitro and in vivo/β-lapachone
[41, 42]
6[ 13, 22, 43–46]
Tecoma violacea Bark Cancer — 1[ 47]
Boraginaceae
Symphytum oﬃcinale L. Leaf
Leukemia,
cancer, mouth
cancer, skin
cancer
In vitro [48] 5
[23,45,46,49,50]4 Evidence-Based Complementary and Alternative Medicine
Table 1: Continued.
Family/species Plant parts used Indication Pharmacological
study/molecules evaluated
Occurrence
(reference)
Caricaceae
Carica papaya L. Flower, fruit,
latex Wart
In vitro/5,7-dimethoxycoumarin,
Lycopene and Benzyl
isothiocyanate [51–53]
2[ 13, 54]
Caryocaraceae
Caryocar coriaceum Wittm. — Tumors — 1 [55]
Cecropiaceae
Cecropia hololeuca Miq. — Cancerous
wounds —1 [ 56]
Cecropia peltata L. — Cancerous
wounds —1 [ 56]
Celastraceae
Maytenus ilicifolia (Schrad.) Planch. Leaf, root Cancer, skin
cancer, tumors
In vitro/Pristimerin,
6-oxotingenol and Erythrodiol
[57–59]
4[ 16, 37, 60, 61]
Maytenus obtusifolia Mart. Leaf Cancer — 1 [22]
Maytenus rigida Mart. Bark Cancer — 1 [22]
Chenopodiaceae
Chenopodium ambrosioides L. Stem, leaf,
whole plant Cancer In vitro and in vivo/ascaridol
[62, 63] 2[ 13, 31]
Cochlospermaceae
Cochlospermum regium (Schrank) Pilg. Root Cancer — 1 [31]
Crassulaceae
Cotyledon orbiculata L. — Cancer — 1 [64]
Euphorbiaceae
Cnidoscolus obtusifolius Pohl ex Baill. Leaf, ﬂower Cancer and
tumors —3 [ 13, 35, 36]
Cnidoscolus phyllacanthus (M¨ ull. Arg.) Pax & L.
Hoﬀm.
Stem, bark, bast,
l´ atex, root Wart — 2 [13, 21]
Cnidoscolus urens (L.) Arthur Root Cancer — 1 [23]
Croton antisyphiliticus Mart. Leaf Tumors — 1 [65]
Croton urucurana Baill. — Cancer — 1 [55]
Euphorbia phosphorea Mart. Stem, latex Wart — 3 [13, 22, 47]
Euphorbia prostrata Aiton Latex Wart — 3 [13, 22, 47]
Euphorbia tirucalli L. Latex, aerial
parts, leaf
Cancer and
wart — 6[ 15, 16, 22, 64,
66, 67]
Manihot esculenta Crantz Leaf, l´ atex, root Wart In vitro/linamarin, esculentoic
acids A and B [68, 69] 2[ 13, 47]
Fabaceae
Anadenanthera colubrina (Vell.) Brenan Stem, bark, bast,
ﬂower, leaf, fruit Cancer In vivo/acidic
heteropolysaccharide [70] 1[ 13]
Bauhinia forﬁcata Link Leaf Cancer In vitro/HY52 [71]1 [ 60]
Copaifera langsdorﬃi Desf. — Tumors In vitro/kaurenoic acid [72]1 [ 55]
Copaifera multijuga Hayne Oil of fruit Cancer In vitro and in vivo [73]1 [ 22]
Copaifera reticulata Ducke Whole plant Cancer — 1 [22]
Parapiptadenia rigida (Benth.) Brenan — Tumors — 1 [50]
Senna occidentalis (L.) Link Leaf, seed, root Cancer In vitro [74]2 [ 13, 36]
Iridaceae
Eleutherine bulbosa (Mill.) Urb. Leaf, bulb Cancer — 1 [67]Evidence-Based Complementary and Alternative Medicine 5
Table 1: Continued.
Family/species Plant parts used Indication Pharmacological
study/molecules evaluated
Occurrence
(reference)
Lamiaceae
Leucas martinicensis (Jacq.) R. Br. Leaf Benign tumors — 1 [75]
Lecythidaceae
Cariniana rubra Gardner ex Miers Bark Tumors
(myoma) —1 [ 61]
Liliaceae
Aloe arborescens Mill. Leaf Cancer,
prostate cancer
In vitro, in vivo and clinical/Aloin
[76–78]
6[ 15, 16, 64, 66,
79, 80]
Aloe soccotrina DC. Leaf Leukemia — 2 [22, 81]
Aloe vera (L.) Burm. f. Leaf, root, stem
and sap Cancer In vitro and in vivo/aloe-emodin
and aloctin I [82, 83]
8[ 13, 16, 23, 31,
55, 60, 84, 85]
Lythraceae
Lafoensia pacari A. St.-Hil. Bark Cancer — 1 [61]
Malvaceae
Abutilon grandifolium (Willd.) Sweet Leaf Cancer and
myoma —2 [ 16, 79]
Myrcinaceae
Rapanea guianensis Aubl. Branches with
leaf Tumors In vitro/rapanone [86]1 [ 87]
Rapanea umbellata (Mart.) Mez Branches with
leaf Tumors — 1 [87]
Myrtaceae
Myrciaria herbacea O. Berg Root Cancer — 1 [31]
Nyctaginaceae
Boerhavia diﬀusa L. Leaf, root Leukemia In vivo/punarnavine,
boeravinones G and H [88, 89] 1[ 31]
Guapira pernambucensis (Casar.) Lundell Bark Wart — 1 [22]
Papaveraceae
Chelidonium majus L. Latex Wart
In vitro and in vivo/chelidonine,
sanguinarine, chelerythrine, and
nucleases (CMN1 and CMN2)
[90–92]
1[ 15]
Piperaceae
Ottonia leptostachya Kunth Whole plant Wart — 1 [22]
Piper regnellii (Miq.) C. DC. Leaf, aerial parts Myoma — 1 [37]
Plantaginaceae
Plantago australis Lam
Leaf, root,
whole plant, and
inﬂorescence
Tumors,
cancer and
prevent cancer
—3 [ 37, 50, 79]
Plantago major L.
Leaf, root,
whole plant and
inﬂorescence
Prevent cancer In vitro and in vivo [93, 94]1 [ 79]
Plantago tomentosa Lam. — Cancer — 2 [16, 37]
Plumbaginaceae
Plumbago scandens L. Bark, leaf, root,
whole plant Wart In vivo and in vitro/plumbagin
[95, 96] 4[ 13, 21, 22, 25]
Pteridaceae
Adiantum raddianum C. Presl Aerial parts Cancer — 2 [37, 64]
Rubiaceae
Psychotria ipecacuanha (Brot.) Stokes Whole plant Cancer In vitro and in vivo/emetine
[97, 98] 1[ 23]6 Evidence-Based Complementary and Alternative Medicine
Table 1: Continued.
Family/species Plant parts used Indication Pharmacological
study/molecules evaluated
Occurrence
(reference)
Sapindaceae
Cardiospermum oliveirae Ferrucci
Stem, leaf,
ﬂower, aerial
parts
Tumors — 3 [13, 22, 36]
Serjania erecta Radlk. Leaf, root Cancer — 1 [61]
Simaroubaceae
Simaba suﬀruticosa Engl. Root Cancer — 1 [31]
Solanaceae
Capsicum frutescens L. Leaf Tumor In vitro and in vivo/capsaicin
[99, 100] 1[ 60]
Solanum americanum Mill. Leaf Myoma In vitro and in vivo/glycoprotein
and solanine [101, 102] 1[ 60]
Solanum paniculatum L. Root, leaf, fruit Internal
tumors —1 [ 87]
Tiliaceae
Luehea paniculata Mart. Bark, leaf Tumors — 1 [103]
Turneraceae
Turnera ulmifolia L. Leaf, root,
whole plant Cancer — 1 [13]
Verbenaceae
Stachytarpheta cayennensis (Rich.) Vahl Leaf Cancer — 2 [37, 64]
Vitex triﬂora Vahl Leaf, latex Wart — 2 [22, 104]
Violaceae
Viola odorata L. — Cancer In vitro and in vivo/cycloviolacin
O2 [105] 1[ 64]
Vitaceae
Cissus coccinea (Baker) Mart. ex Planch. Leaf, root Wart — 1 [22]
Cissus decidua Lombardi
Stem, leaf,
ﬂower, aerial
parts
Cancer — 3 [13, 22, 36]
Cissus duarteana Cambess. Sap and root Wart — 1 [103]
Cissus erosa Rich. Aerial parts Wart — 2 [21, 22]
Zingiberaceae
Costus spiralis (Jacq.) Roscoe — Prostate cancer — 1 [84]
(Table 1).Themorehighlyrepresentedbotanicfamilieswere:
Euphorbiaceae (9 spp.), Fabaceae (7 spp.), Apocynaceae (6
spp.), Asteraceae, and Vitaceae (4 spp. each). The genera
with the highest number of species were: Cissus (4 spp.),
Himatanthus, Maytenus, Cnidoscolus, Euphorbia, Copaifera,
Aloe,a n dPlantago (3 spp. each). The plants most frequently
cited were Aloe vera (eight), Aloe arborescens, Euphorbia
tirucalli and Tabebuia impetiginosa (each cited six times),
and Symphytum oﬃcinale (ﬁve). Of these, only Tabebuia
impetiginosa is native to Brazil.
Majority of the plant species were reported to be used
for the treatment of tumors and cancer in general (69.05%),
and a smaller proportion (30.95%) were reported to be used
for the treatment of speciﬁc tumors, such as warts, leukemia,
myoma, or cancers of the mouth, skin, and prostate. S.
oﬃcinale stands out from the other plants because it was
reported to be used for the treatment of cancer in general,
leukemia and mouth and skin cancers. In vitro and in vivo
studies related directly to tumors of animal origin were not
found for 55 (64.29%) of the species analyzed here.
3.3. Survey of Ethnobotanical Studies. We found at least one
typeofpharmacologicalstudyfor35.71%oftheplantspecies
(30 taxa). Considering only the plant species for which
we found pharmacological studies, we found only 14.29%
(4 taxa) of the species or their molecules were used for
clinical studies, and 39.39% of the plants (12 taxa) were used
to perform in vitro studies of their extracts or associated
molecules (Figure 1). From the plants for which we found
studies, approximately 30 molecules with in vitro and/or in
vivoantitumor activity have been isolated (Figures 2 and 3).
Molecules or extracts that exhibited antitumor activity
mainly act by inducing cell cycle arrest and/or apoptosis.Evidence-Based Complementary and Alternative Medicine 7
84 medicinal plants
cited as being anti-
tumor
64.29%
no studies
35.71% with
pharmacological
studies
32 molecules
isolated
3 extracts with
clinical evaluations
10 molecules with
studies in vivo
1 molecule with
clinical evaluations
14.28% only
with in
vitro studies
(12 species)
21.431% with in
vitro and in vivo
studies (18 species)
Figure 1: Level of pharmacologicalstudies related to tumors of medicinal plants cited as being antitumor by traditional and nontraditional
communities in Brazil.
Preclinical studies in cancer research have focused on the
search for molecules that exhibit proapoptotic activity and
promote cell cycle arrest. In our analysis, we found a
great diversity of molecules of diﬀerent chemical classes
that exhibited anticancer activity, including alkaloids, pep-
tides, glycoproteins, carotenoids, terpenes, carbohydrates,
quinines, and phenolic compounds.
We summarize, in Table 1, the studies on the antitumor
activity of each of the plant species we found in our search
and the molecules that have been isolated from them.
4.Discussion
4.1. Survey of Ethnobotanical Studies. The highest numbers
of studies citing antitumor plants were published between
2000 and 2008. This pattern is likely associated with the
increase of publications relating to ethnobotanical studies
conductedin Brazil duringthis time [106].The lownumbers
of citations of plants identiﬁed as antitumor, with an overall
average below 3 species per article, depicts in general, that
local communities have a small repertoire of plants for the
treatment of tumors when compared to more recurrent
diseases and disorders, such as inﬂammation, ﬂu, infections
and parasites, which is focused on the most assiduous
diseases. In a survey of the medicinal plants known and used
by the people of the Caatinga biome, Albuquerqueet al. [13]
documented a total of 389 species, of which more than half
were used to treat diseases of the digestive, respiratory, and
genitourinary systems, while only 8 species (2%) were used
to treat tumors. However, it is diﬃcult to diagnose cancer
using traditional medicine because the signs and symptoms
of diﬀerent types of cancer are not speciﬁc and are confused
with those of other diseases.
Mostoftheselected studieswere conductedinurbanand
farming areas and areas with traditional healers, probably
because: (a) these populations have a greater number of
studies in Brazil (see [106]), (b) these populations have a
greater knowledge of the plants used to treat tumors, and (c)
these populations are more susceptible to the inﬂuences of
other cultures and other external sources, such as the media
(similar to what happened to the wide dissemination of Red
Lapacho (Tabebuia impetiginosa, by magazine O’Cruzeiro
published in 1967 reports of miraculous healing in cancer
patients)) [107] and the public markets (deﬁned as public
spaces where many types of products are sold, including
medicinal plants and their derivatives, and as a forum for the
exchange of cultural information) [23]. The low similarity
betweentheplantspeciesfromthepopulationslocatedinthe
diﬀerent ecosystems (14.29%) suggests that the populations
have a greater knowledge of medicinal plants from the local
ﬂora for the treatment of tumors.
4.2. Survey of Ethnobotanical Studies. Our survey of the
84 species of plants used in Brazil for the treatment of
tumors likely represents only a fraction of the plants used for
this purpose because studies published in local or regional
journals may not be indexed in national and/or international
databases. Additionally, not all communities in Brazil have
been suﬃciently studied.
The Euphorbiaceae, Fabaceae, Apocynaceae, and Aster-
aceae families, which had the largest number of species
represented in this study, were also the most represented in8 Evidence-Based Complementary and Alternative Medicine
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an ethnopharmacological study aimed at selecting plants for
use in experimental studies; one of the criteria for species
selection was they present categories of use predeﬁned,
among those cited for the treatment of cancers, tumors,
ulcers, sore mouth, and throat [4]. Four plant species
should be highlighted for being highly cited in the studies
and for their greater presence in the diﬀerent ecosystems
and regions of Brazil: A .v e r a ,A .a r b o r e s c e n s ,E .t i r u c a l l i ,
and T. impetiginosa. These plants are widely publicized in
Brazil by the virtual media as having anticancer properties.
Furthermore, there are several products containing A. vera
and T. impetiginosa that are explicitly marketed over the
internet for the treatment of cancer; however, these claims
lack scientiﬁc support.
This scenario, the low numbers of citations of plants
identiﬁed as antitumor considering only one local com-
munity studied, has some implications if we want to
use an ethnobotanical/ethnopharmacological approach for
the search of new molecules with antineoplastic activity
derived from the Brazilian ﬂora. First, targeted ethnobotan-
ical/ethnopharmacological studies in speciﬁc communities
can easily result in no or few species being directly reported
asantitumor.Shouldonewanttoperform apharmacological
study with less than 100 plants (triage) based on the popular
knowledgeofasinglecommunity,otherselectioncriteriawill
be required besides a suggestion that a plant can be used
to treat cancer. For the selection of species used in popular
medicine, Santos and Elisabetsky [4] took into consideration
not only the direct evidence that a plant was used for
the treatment of cancer and tumors but also the signs
and symptoms associated with certain cancers, which were
related to the cell lines available for screening, and reports
of the toxic eﬀects common to chemotherapeutic agents
(quantiﬁed by the order of importance). These selection
criteria resulted in the identiﬁcation of a greater number of
candidate species for use in laboratory studies.
Second, a greater number of ethnobotanical/ethno-
pharmacological studies conducted and data collected on
a regional scale will increase the possibilities of identifying
new molecules with antitumor eﬀects. For example, using
lung and breast cancer cell lines, Lee and Houghton [108]
evaluatedthe in vitro cytotoxic activity of seven plant species
used in traditional Malaysian and Thai medicine to treat
cancer. Eleven extracts from six plant species (85.71% of
theselectedplants)exhibitedantiproliferativeactivityagainst
one of these cell lines, with IC50 values ranging from 2.7
to 35.8μg/mL. These extracts are of interest for future
investigations.
4.3. Survey of Ethnobotanical Studies. The large number of
plant species have not been analyzed for their antitumor
potential (64.29%, 54 taxa) or have only been studied in
vitro (14.29%, 12 taxa) indicates there is ample space in
the ﬁeld for future investigations of the anticancer activity
of such plants in Brazil. In general, the plants that were
used in various experimental studies showed signiﬁcant
results in the pharmacological models used, and these results
corroborated their popular use. Many researchers selected
plants used in alternative and complementary medicine to
treat cancer, with the goal of evaluating the antitumoral
activity. Satisfactory results has been found for both in vitro
and in vivo [109, 110] activities, demonstrating that plant
species used in popular medicine are a promising source for
new molecules.
We propose the following suggestions for the plant
s p e c i e ss u r v e y e di nt h i ss t u d y :( 1 )f o rp l a n t st h a th a v e
not been analyzed for their antitumor potential by any
pharmacodynamic study, it is necessary to perform in vitro
experiments with diﬀerent solvents and using diﬀerent
cancer cell lines;,(2) for species from which active extracts
have been isolated, including H. obovatus, A. hispidum, P.
major,a n dS. occidentalis, it is necessary to identify the
molecule(s) responsible for their biological activity, (3) for
the species from which active extracts with known chemical
structure(s)havebeenisolatedandwhich havedemonstrated
signiﬁcant activity in vitro, it is necessary to proceed with
studies in vivo (e.g., V. odorata (cicloviolacina), C. oﬃcinalis
(calenduloside), M. ilicifolia (pristimerina, 6-oxotingenol
and erythrodiol), B. forﬁcata (HY52), and C. langsdorﬃi
(kaurenoic acid)), and (4) for the species that have met the
previous requirements, it is necessary to make an extensive
in vivo biological evaluation and subsequently proceed
with clinical evaluations (e.g., S. marianum (silibinin),T .
impetiginosa (β-lapachone),P .s c a n d e n s(plumbagin), and C.
frutescens (capsaicin)). The species addressed here constitute
interesting objects for future studies for the various profes-
sionals in the ﬁeld of natural products.
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